Literature DB >> 19244328

Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus.

Robert A Love1, Oleg Brodsky, Michael J Hickey, Peter A Wells, Ciarán N Cronin.   

Abstract

A new protein expression vector design utilizing an N-terminal six-histidine tag and tobacco etch virus protease cleavage site upstream of the hepatitis C virus NS5A sequence has resulted in a more straightforward purification method and improved yields of purified NS5A domain I protein. High-resolution diffracting crystals of NS5A domain I (amino acids 33 to 202) [NS5A(33-202)] were obtained by using detergent additive crystallization screens, leading to the structure of a homodimer which is organized differently from that published previously (T. L. Tellinghuisen, J. Marcotrigiano, and C. M. Rice, Nature 435:374-379, 2005) yet is consistent with a membrane association model for NS5A. The monomer-monomer interface of NS5A(33-202) features an extensive buried surface area involving the most-highly conserved face of each monomer. The two alternate structural forms of domain I now available may be indicative of the multiple roles emerging for NS5A in viral RNA replication and viral particle assembly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19244328      PMCID: PMC2668466          DOI: 10.1128/JVI.02352-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

2.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

3.  Shape complementarity at protein/protein interfaces.

Authors:  M C Lawrence; P M Colman
Journal:  J Mol Biol       Date:  1993-12-20       Impact factor: 5.469

4.  Protein-protein interactions between hepatitis C virus nonstructural proteins.

Authors:  Maria Dimitrova; Isabelle Imbert; Marie Paule Kieny; Catherine Schuster
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Efficient initiation of HCV RNA replication in cell culture.

Authors:  K J Blight; A A Kolykhalov; C M Rice
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

Review 6.  Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication?

Authors:  Ying Huang; Kirk Staschke; Raffaele De Francesco; Seng-Lai Tan
Journal:  Virology       Date:  2007-04-02       Impact factor: 3.616

7.  The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation.

Authors:  S I Asabe; Y Tanji; S Satoh; T Kaneko; K Kimura; K Shimotohno
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

8.  Regulation of hepatitis C virion production via phosphorylation of the NS5A protein.

Authors:  Timothy L Tellinghuisen; Katie L Foss; Jason Treadaway
Journal:  PLoS Pathog       Date:  2008-03-21       Impact factor: 6.823

9.  Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A.

Authors:  François Penin; Volker Brass; Nicole Appel; Stephanie Ramboarina; Roland Montserret; Damien Ficheux; Hubert E Blum; Ralf Bartenschlager; Darius Moradpour
Journal:  J Biol Chem       Date:  2004-07-07       Impact factor: 5.157

10.  Purification and characterization of hepatitis C virus non-structural protein 5A expressed in Escherichia coli.

Authors:  Luyun Huang; Elena V Sineva; Michele R S Hargittai; Suresh D Sharma; Mehul Suthar; Kevin D Raney; Craig E Cameron
Journal:  Protein Expr Purif       Date:  2004-09       Impact factor: 1.650

View more
  106 in total

Review 1.  Architecture and biogenesis of plus-strand RNA virus replication factories.

Authors:  David Paul; Ralf Bartenschlager
Journal:  World J Virol       Date:  2013-05-12

2.  Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain.

Authors:  Andrew Kohlway; Nathan Pirakitikulr; Francisco N Barrera; Olga Potapova; Donald M Engelman; Anna M Pyle; Brett D Lindenbach
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

3.  Preclinical characterization of GSK2336805, a novel inhibitor of hepatitis C virus replication that selects for resistance in NS5A.

Authors:  Jill Walker; Renae Crosby; Amy Wang; Ermias Woldu; Jessica Vamathevan; Christian Voitenleitner; Shihyun You; Katja Remlinger; Maoshang Duan; Wieslaw Kazmierski; Robert Hamatake
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

Review 4.  Anti-HCV drugs in the pipeline.

Authors:  Priscilla L Yang; Min Gao; Kai Lin; Qingsong Liu; Valerie A Villareal
Journal:  Curr Opin Virol       Date:  2011-11-13       Impact factor: 7.090

5.  Expanding the proteome of an RNA virus by phosphorylation of an intrinsically disordered viral protein.

Authors:  Daniel G Cordek; Tayler J Croom-Perez; Jungwook Hwang; Michele R S Hargittai; Chennareddy V Subba-Reddy; Qingxia Han; Maria Fernanda Lodeiro; Gang Ning; Thomas S McCrory; Jamie J Arnold; Hasan Koc; Brett D Lindenbach; Scott A Showalter; Craig E Cameron
Journal:  J Biol Chem       Date:  2014-07-16       Impact factor: 5.157

Review 6.  Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.

Authors:  Troels K H Scheel; Charles M Rice
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 7.  The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA.

Authors:  You Li; Daisuke Yamane; Takahiro Masaki; Stanley M Lemon
Journal:  Nat Rev Microbiol       Date:  2015-08-10       Impact factor: 60.633

8.  TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.

Authors:  D G Cordek; J T Bechtel; A T Maynard; W M Kazmierski; C E Cameron
Journal:  Drugs Future       Date:  2011-09       Impact factor: 0.148

9.  Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzee.

Authors:  MinKyung Yi; Fengyu Hu; Michael Joyce; Vikas Saxena; Christoph Welsch; Deborah Chavez; Bernadette Guerra; Daisuke Yamane; Ronald Veselenak; Rick Pyles; Christopher M Walker; Lorne Tyrrell; Nigel Bourne; Robert E Lanford; Stanley M Lemon
Journal:  J Virol       Date:  2014-01-15       Impact factor: 5.103

10.  Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A.

Authors:  Fiona Fernandes; Israr-ul H Ansari; Rob Striker
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.